Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China

Bedaquiline has been widely used as a part of combination dosage regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB) patients with limited options. Although the effectiveness and safety of bedaquiline have been demonstrated in clinical trials, limited studies have investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jin, Chen, Shuyan, Rao, Weiqiao, Fu, Liang, Zhang, Jiancong, Liao, Yunli, Zhang, Ying, Lv, Ning, Deng, Guofang, Yang, Shijin, Lin, Liang, Li, Lujin, Liu, Siqi, Qu, Jiuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578397/
https://www.ncbi.nlm.nih.gov/pubmed/36106884
http://dx.doi.org/10.1128/aac.00811-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578397/
https://www.ncbi.nlm.nih.gov/pubmed/36106884
http://dx.doi.org/10.1128/aac.00811-22

Ejemplares similares